INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 99 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $99,000 | -26.7% | 10,707 | -7.6% | 0.00% | – |
| Q3 2020 | $135,000 | -39.5% | 11,583 | +39.7% | 0.00% | – |
| Q2 2020 | $223,000 | +156.3% | 8,292 | -29.4% | 0.00% | – |
| Q1 2020 | $87,000 | +40.3% | 11,743 | -38.0% | 0.00% | – |
| Q4 2019 | $62,000 | +63.2% | 18,938 | +1.4% | 0.00% | – |
| Q3 2019 | $38,000 | -11.6% | 18,683 | +27.2% | 0.00% | – |
| Q2 2019 | $43,000 | -21.8% | 14,683 | 0.0% | 0.00% | – |
| Q1 2019 | $55,000 | -16.7% | 14,683 | +23.8% | 0.00% | – |
| Q3 2018 | $66,000 | -21.4% | 11,857 | -44.4% | 0.00% | – |
| Q2 2018 | $84,000 | +20.0% | 21,344 | +104.6% | 0.00% | – |
| Q4 2015 | $70,000 | -1.4% | 10,430 | -15.6% | 0.00% | – |
| Q3 2015 | $71,000 | -47.8% | 12,360 | -26.1% | 0.00% | – |
| Q2 2015 | $136,000 | +13.3% | 16,720 | +13.9% | 0.00% | – |
| Q1 2015 | $120,000 | -13.7% | 14,675 | -3.0% | 0.00% | – |
| Q4 2014 | $139,000 | -71.3% | 15,132 | -69.3% | 0.00% | – |
| Q3 2014 | $485,000 | +133.2% | 49,352 | +155.8% | 0.00% | – |
| Q2 2014 | $208,000 | – | 19,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |